<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">32374065</PMID><DateCompleted><Year>2021</Year><Month>04</Month><Day>09</Day></DateCompleted><DateRevised><Year>2022</Year><Month>12</Month><Day>13</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1600-0854</ISSN><JournalIssue CitedMedium="Internet"><Volume>21</Volume><Issue>7</Issue><PubDate><Year>2020</Year><Month>Jul</Month></PubDate></JournalIssue><Title>Traffic (Copenhagen, Denmark)</Title><ISOAbbreviation>Traffic</ISOAbbreviation></Journal><ArticleTitle>Regulation of RNA granules by FMRP and implications for neurological diseases.</ArticleTitle><Pagination><StartPage>454</StartPage><EndPage>462</EndPage><MedlinePgn>454-462</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1111/tra.12733</ELocationID><Abstract><AbstractText>RNA granule formation, which can be regulated by RNA-binding proteins (RBPs) such as fragile X mental retardation protein (FMRP), acts as a mechanism to control both the repression and subcellular localization of translation. Dysregulated assembly of RNA granules has been implicated in multiple neurological disorders, such as amyotrophic lateral sclerosis. Thus, it is crucial to understand the cellular pathways impinging upon granule assembly or disassembly. The goal of this review is to summarize recent advances in our understanding of the role of the RBP, FMRP, in translational repression underlying RNA granule dynamics, mRNA transport and localized. We summarize the known mechanisms of translational regulation by FMRP, the role of FMRP in RNA transport granules, fragile X granules and stress granules. Focusing on the emerging link between FMRP and stress granules, we propose a model for how hyperassembly and hypoassembly of RNA granules may contribute to neurological diseases.</AbstractText><CopyrightInformation>&#xa9; 2020 John Wiley &amp; Sons A/S. Published by John Wiley &amp; Sons Ltd.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Lai</LastName><ForeName>Austin</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Cell Biology, Emory University School of Medicine, Atlanta, Georgia, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Valdez-Sinon</LastName><ForeName>Arielle N</ForeName><Initials>AN</Initials><AffiliationInfo><Affiliation>Department of Cell Biology, Emory University School of Medicine, Atlanta, Georgia, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bassell</LastName><ForeName>Gary J</ForeName><Initials>GJ</Initials><Identifier Source="ORCID">0000-0003-2622-0127</Identifier><AffiliationInfo><Affiliation>Department of Cell Biology, Emory University School of Medicine, Atlanta, Georgia, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>F31 NS101932</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 MH109026</GrantID><Acronym>MH</Acronym><Agency>NIMH NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>T32 GM008169</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>1R01MH109026, NIH F31NS101932 (ANV)</GrantID><Agency>National Institute of Health</Agency><Country>International</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Traffic</MedlineTA><NlmUniqueID>100939340</NlmUniqueID><ISSNLinking>1398-9219</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>139135-51-6</RegistryNumber><NameOfSubstance UI="D051860">Fragile X Mental Retardation Protein</NameOfSubstance></Chemical><Chemical><RegistryNumber>63231-63-0</RegistryNumber><NameOfSubstance UI="D012313">RNA</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003594" MajorTopicYN="N">Cytoplasmic Granules</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051860" MajorTopicYN="Y">Fragile X Mental Retardation Protein</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012313" MajorTopicYN="N">RNA</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">FMRP</Keyword><Keyword MajorTopicYN="N">RNA</Keyword><Keyword MajorTopicYN="N">granules</Keyword><Keyword MajorTopicYN="N">mRNP granules</Keyword><Keyword MajorTopicYN="N">protein synthesis</Keyword><Keyword MajorTopicYN="N">stress granules</Keyword></KeywordList><CoiStatement>CONFLICT OF INTEREST. The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>2</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2020</Year><Month>4</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>4</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>5</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>4</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>5</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32374065</ArticleId><ArticleId IdType="mid">NIHMS1609686</ArticleId><ArticleId IdType="pmc">PMC7377269</ArticleId><ArticleId IdType="doi">10.1111/tra.12733</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Martin KC, Barad M, Kandel ER. Local protein synthesis and its role in synapse-specific plasticity. Curr Opin Neurobiol. 2000;10(5):587&#x2013;592. 10.1016/s0959-4388(00)00128-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0959-4388(00)00128-8</ArticleId><ArticleId IdType="pubmed">11084321</ArticleId></ArticleIdList></Reference><Reference><Citation>Steward O, Schuman EM. Compartmentalized synthesis and degradation of proteins in neurons. Neuron. 2003;40(2):347&#x2013;359. 10.1016/s0896-6273(03)00635-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0896-6273(03)00635-4</ArticleId><ArticleId IdType="pubmed">14556713</ArticleId></ArticleIdList></Reference><Reference><Citation>Pfeiffer BE, Huber KM. Current advances in local protein synthesis and synaptic plasticity. J Neurosci. 2006;26(27):7147&#x2013;7150. 10.1523/JNEUROSCI.1797-06.2006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.1797-06.2006</ArticleId><ArticleId IdType="pmc">PMC6673933</ArticleId><ArticleId IdType="pubmed">16822970</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin AC, Holt CE. Function and regulation of local axonal translation. Curr Opin Neurobiol. 2008;18(1):60&#x2013;68. 10.1016/j.conb.2008.05.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.conb.2008.05.004</ArticleId><ArticleId IdType="pmc">PMC3687333</ArticleId><ArticleId IdType="pubmed">18508259</ArticleId></ArticleIdList></Reference><Reference><Citation>Greer PL, Hanayama R, Bloodgood BL, et al. The Angelman syndrome protein Ube3A regulates synapse development by ubiquitinating arc. Cell. 2010;140(5):704&#x2013;716. 10.1016/j.cell.2010.01.026.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2010.01.026</ArticleId><ArticleId IdType="pmc">PMC2843143</ArticleId><ArticleId IdType="pubmed">20211139</ArticleId></ArticleIdList></Reference><Reference><Citation>Kishino T, Lalande M, Wagstaff J. UBE3A/E6-AP mutations cause Angelman syndrome. Nat Genet. 1997;15(1):70&#x2013;73. 10.1038/ng0197-70.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng0197-70</ArticleId><ArticleId IdType="pubmed">8988171</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee SY, Ramirez J, Franco M, et al. Ube3a, the E3 ubiquitin ligase causing Angelman syndrome and linked to autism, regulates protein homeostasis through the proteasomal shuttle Rpn10. Cell Mol Life Sci. 2014;71(14):2747&#x2013;2758. 10.1007/s00018-013-1526-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00018-013-1526-7</ArticleId><ArticleId IdType="pubmed">24292889</ArticleId></ArticleIdList></Reference><Reference><Citation>Tastet J, Decalonne L, Marouillat S, et al. Mutation screening of the ubiquitin ligase gene RNF135 in French patients with autism. Psychiatr Genet. 2015;25(6):263&#x2013;267. 10.1097/YPG.0000000000000100.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/YPG.0000000000000100</ArticleId><ArticleId IdType="pubmed">26368817</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsai N-P, Wilkerson JR, Guo W, et al. Multiple autism-linked genes mediate synapse elimination via proteasomal degradation of a synaptic scaffold PSD-95. Cell. 2012;151(7):1581&#x2013;1594. 10.1016/j.cell.2012.11.040.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2012.11.040</ArticleId><ArticleId IdType="pmc">PMC3530171</ArticleId><ArticleId IdType="pubmed">23260144</ArticleId></ArticleIdList></Reference><Reference><Citation>Yi JJ, Berrios J, Newbern JM, et al. An autism-linked mutation disables phosphorylation control of UBE3A. Cell. 2015;162(4):795&#x2013;807. 10.1016/j.cell.2015.06.045.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2015.06.045</ArticleId><ArticleId IdType="pmc">PMC4537845</ArticleId><ArticleId IdType="pubmed">26255772</ArticleId></ArticleIdList></Reference><Reference><Citation>Gross C, Bassell GJ. Excess protein synthesis in FXS patient lymphoblastoid cells can be rescued with a p110&#x3b2;-selective inhibitor. Mol Med. 2012;18:336&#x2013;345. 10.2119/molmed.2011.00363.</Citation><ArticleIdList><ArticleId IdType="doi">10.2119/molmed.2011.00363</ArticleId><ArticleId IdType="pmc">PMC3356413</ArticleId><ArticleId IdType="pubmed">22207187</ArticleId></ArticleIdList></Reference><Reference><Citation>Gross C, Nakamoto M, Yao X, et al. Excess phosphoinositide 3-kinase subunit synthesis and activity as a novel therapeutic target in fragile X syndrome. J Neurosci. 2010;30(32):10624&#x2013;10638. 10.1523/JNEUROSCI.0402-10.2010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.0402-10.2010</ArticleId><ArticleId IdType="pmc">PMC2924772</ArticleId><ArticleId IdType="pubmed">20702695</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharma A, Hoeffer CA, Takayasu Y, et al. Dysregulation of mTOR signaling in fragile X syndrome. J Neurosci. 2010;30(2):694&#x2013;702. 10.1523/JNEUROSCI.3696-09.2010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.3696-09.2010</ArticleId><ArticleId IdType="pmc">PMC3665010</ArticleId><ArticleId IdType="pubmed">20071534</ArticleId></ArticleIdList></Reference><Reference><Citation>Bhakar AL, D&#xf6;len G, Bear MF. The pathophysiology of fragile X (and what it teaches us about synapses). Annu Rev Neurosci. 2012;35:417&#x2013;443. 10.1146/annurev-neuro-060909-153138.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-neuro-060909-153138</ArticleId><ArticleId IdType="pmc">PMC4327822</ArticleId><ArticleId IdType="pubmed">22483044</ArticleId></ArticleIdList></Reference><Reference><Citation>Richter JD, Bassell GJ, Klann E. Dysregulation and restoration of translational homeostasis in fragile X syndrome. Nat Rev Neurosci. 2015;16(10):595&#x2013;605. 10.1038/nrn4001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrn4001</ArticleId><ArticleId IdType="pmc">PMC4688896</ArticleId><ArticleId IdType="pubmed">26350240</ArticleId></ArticleIdList></Reference><Reference><Citation>Bassell GJ, Warren ST. Fragile X syndrome: loss of local mRNA regulation alters synaptic development and function. Neuron. 2008;60(2): 201&#x2013;214. 10.1016/j.neuron.2008.10.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2008.10.004</ArticleId><ArticleId IdType="pmc">PMC3691995</ArticleId><ArticleId IdType="pubmed">18957214</ArticleId></ArticleIdList></Reference><Reference><Citation>Banerjee A, Ifrim MF, Valdez AN, Raj N, Bassell GJ. Aberrant RNA translation in fragile X syndrome: from FMRP mechanisms to emerging therapeutic strategies. Brain Res. 2018;1693(pt A):24&#x2013;36. 10.1016/j.brainres.2018.04.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brainres.2018.04.008</ArticleId><ArticleId IdType="pmc">PMC7377270</ArticleId><ArticleId IdType="pubmed">29653083</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang HL, Eom T, Oleynikov Y, et al. Neurotrophin-induced transport of a beta-actin mRNP complex increases beta-actin levels and stimulates growth cone motility. Neuron. 2001;31(2):261&#x2013;275. 10.1016/s0896-6273(01)00357-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0896-6273(01)00357-9</ArticleId><ArticleId IdType="pubmed">11502257</ArticleId></ArticleIdList></Reference><Reference><Citation>Kiebler MA, Bassell GJ. Neuronal RNA granules: movers and makers. Neuron. 2006;51(6):685&#x2013;690. 10.1016/j.neuron.2006.08.021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2006.08.021</ArticleId><ArticleId IdType="pubmed">16982415</ArticleId></ArticleIdList></Reference><Reference><Citation>Didiot M-C, Subramanian M, Flatter E, Mandel J-L, Moine H. Cells lacking the fragile X mental retardation protein (FMRP) have normal RISC activity but exhibit altered stress granule assembly. Mol Biol Cell. 2009;20(1):428&#x2013;437. 10.1091/mbc.e08-07-0737.</Citation><ArticleIdList><ArticleId IdType="doi">10.1091/mbc.e08-07-0737</ArticleId><ArticleId IdType="pmc">PMC2613094</ArticleId><ArticleId IdType="pubmed">19005212</ArticleId></ArticleIdList></Reference><Reference><Citation>Protter DSW, Parker R. Principles and properties of stress granules. Trends Cell Biol. 2016;26(9):668&#x2013;679. https://doi.org/10.10167j.tcb.2016.05.004.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4993645</ArticleId><ArticleId IdType="pubmed">27289443</ArticleId></ArticleIdList></Reference><Reference><Citation>Wolozin B, Ivanov P. Stress granules and neurodegeneration. Nat Rev Neurosci. 2019;20(11):649&#x2013;666. 10.1038/s41583-019-0222-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41583-019-0222-5</ArticleId><ArticleId IdType="pmc">PMC6986315</ArticleId><ArticleId IdType="pubmed">31582840</ArticleId></ArticleIdList></Reference><Reference><Citation>Gareau C, Houssin E, Martel D, et al. Characterization of fragile X mental retardation protein recruitment and dynamics in Drosophila stress granules. PLoS One. 2013;8(2):e55342 10.1371/journal.pone.0055342.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0055342</ArticleId><ArticleId IdType="pmc">PMC3567066</ArticleId><ArticleId IdType="pubmed">23408971</ArticleId></ArticleIdList></Reference><Reference><Citation>Ascano M, Mukherjee N, Bandaru P, et al. FMRP targets distinct mRNA sequence elements to regulate protein expression. Nature. 2012;492(7429):382&#x2013;386. 10.1038/nature11737.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature11737</ArticleId><ArticleId IdType="pmc">PMC3528815</ArticleId><ArticleId IdType="pubmed">23235829</ArticleId></ArticleIdList></Reference><Reference><Citation>Darnell JC, Fraser CE, Mostovetsky O, et al. Kissing complex RNAs mediate interaction between the Fragile-X mental retardation protein KH2 domain and brain polyribosomes. Genes Dev. 2005;19(8):903&#x2013;918. 10.1101/gad.1276805.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/gad.1276805</ArticleId><ArticleId IdType="pmc">PMC1080130</ArticleId><ArticleId IdType="pubmed">15805463</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramos A, Hollingworth D, Pastore A. G-quartet-dependent recognition between the FMRP RGG box and RNA. RNA. 2003;9(10):1198&#x2013;1207. 10.1261/rna.5960503.</Citation><ArticleIdList><ArticleId IdType="doi">10.1261/rna.5960503</ArticleId><ArticleId IdType="pmc">PMC1370484</ArticleId><ArticleId IdType="pubmed">13130134</ArticleId></ArticleIdList></Reference><Reference><Citation>Antar LN, Afroz R, Dictenberg JB, Carroll RC, Bassell GJ. Metabotropic glutamate receptor activation regulates fragile x mental retardation protein and FMR1 mRNA localization differentially in dendrites and at synapses. J Neurosci. 2004;24(11):2648&#x2013;2655. 10.1523/JNEUR0SCI.0099-04.2004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUR0SCI.0099-04.2004</ArticleId><ArticleId IdType="pmc">PMC6729525</ArticleId><ArticleId IdType="pubmed">15028757</ArticleId></ArticleIdList></Reference><Reference><Citation>Ifrim MF, Williams KR, Bassell GJ. Single-molecule imaging of PSD-95 mRNA translation in dendrites and its dysregulation in a mouse model of fragile X syndrome. J Neurosci. 2015;35(18):7116&#x2013;7130. 10.1523/JNEUROSCI.2802-14.2015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.2802-14.2015</ArticleId><ArticleId IdType="pmc">PMC4420780</ArticleId><ArticleId IdType="pubmed">25948262</ArticleId></ArticleIdList></Reference><Reference><Citation>Darnell JC, Van Driesche SJ, Zhang C, et al. FMRP stalls ribosomal translocation on mRNAs linked to synaptic function and autism. Cell. 2011;146(2):247&#x2013;261. 10.1016/j.cell.2011.06.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2011.06.013</ArticleId><ArticleId IdType="pmc">PMC3232425</ArticleId><ArticleId IdType="pubmed">21784246</ArticleId></ArticleIdList></Reference><Reference><Citation>Jin P, Zarnescu DC, Ceman S, et al. Biochemical and genetic interaction between the fragile X mental retardation protein and the micro-RNA pathway. Nat Neurosci. 2004;7(2):113&#x2013;117. 10.1038/nn1174.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn1174</ArticleId><ArticleId IdType="pubmed">14703574</ArticleId></ArticleIdList></Reference><Reference><Citation>Muddashetty RS, Nalavadi VC, Gross C, et al. Reversible inhibition of PSD-95 mRNA translation by miR-125a, FMRP phosphorylation, and mGluR signaling. Mol Cell. 2011;42(5):673&#x2013;688. 10.1016/j.molcel.2011.05.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molcel.2011.05.006</ArticleId><ArticleId IdType="pmc">PMC3115785</ArticleId><ArticleId IdType="pubmed">21658607</ArticleId></ArticleIdList></Reference><Reference><Citation>Napoli I, Mercaldo V, Boyl PP, et al. The fragile X syndrome protein represses activity-dependent translation through CYFIP1, a new 4E-BP. Cell. 2008;134(6):1042&#x2013;1054. 10.1016/j.cell.2008.07.031.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2008.07.031</ArticleId><ArticleId IdType="pubmed">18805096</ArticleId></ArticleIdList></Reference><Reference><Citation>Ronesi JA, Collins KA, Hays SA, et al. Disrupted Homer scaffolds mediate abnormal mGluR5 function in a mouse model of fragile X syndrome. Nat Neurosci. 2012;15(3):431&#x2013;440, S1. 10.1038/nn.3033.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.3033</ArticleId><ArticleId IdType="pmc">PMC3288402</ArticleId><ArticleId IdType="pubmed">22267161</ArticleId></ArticleIdList></Reference><Reference><Citation>Gkogkas CG, Khoutorsky A, Cao R, et al. Pharmacogenetic inhibition of eIF4E-dependent Mmp9 mRNA translation reverses fragile X syndrome-like phenotypes. Cell Rep. 2014;9(5):1742&#x2013;1755. 10.1016/j.celrep.2014.10.064.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2014.10.064</ArticleId><ArticleId IdType="pmc">PMC4294557</ArticleId><ArticleId IdType="pubmed">25466251</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu X-L, Li Y, Wang F, Gao F-B. The steady-state level of the nervous-system-specific microRNA-124a is regulated by dFMR1 in Drosophila. J Neurosci. 2008;28(46):11883&#x2013;11889. 10.1523/JNEUROSCI.4114-08.2008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.4114-08.2008</ArticleId><ArticleId IdType="pmc">PMC2605156</ArticleId><ArticleId IdType="pubmed">19005053</ArticleId></ArticleIdList></Reference><Reference><Citation>Nalavadi VC, Muddashetty RS, Gross C, Bassell GJ. Dephosphorylation-induced ubiquitination and degradation of FMRP in dendrites: a role in immediate early mGluR-stimulated translation. J Neurosci. 2012;32(8):2582&#x2013;2587. 10.1523/JNEUROSCI.5057-11.2012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.5057-11.2012</ArticleId><ArticleId IdType="pmc">PMC3427762</ArticleId><ArticleId IdType="pubmed">22357842</ArticleId></ArticleIdList></Reference><Reference><Citation>Darnell JC, Jensen KB, Jin P, Brown V, Warren ST, Darnell RB. Fragile X mental retardation protein targets G quartet mRNAs important for neuronal function. Cell. 2001;107(4):489&#x2013;499. 10.1016/s0092-8674(01)00566-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0092-8674(01)00566-9</ArticleId><ArticleId IdType="pubmed">11719189</ArticleId></ArticleIdList></Reference><Reference><Citation>Anderson BR, Chopra P, Suhl JA, Warren ST, Bassell GJ. Identification of consensus binding sites clarifies FMRP binding determinants. Nucleic Acids Res. 2016;44(14):6649&#x2013;6659. 10.1093/nar/gkw593.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkw593</ArticleId><ArticleId IdType="pmc">PMC5001617</ArticleId><ArticleId IdType="pubmed">27378784</ArticleId></ArticleIdList></Reference><Reference><Citation>Goering R, Hudish LI, Guzman BB, et al. FMRP promotes RNA localization to neuronal projections through interactions between its RGG domain and G-quadruplex RNA sequences. bioRxiv. 2019;784728 10.1101/784728.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/784728</ArticleId><ArticleId IdType="pmc">PMC7279889</ArticleId><ArticleId IdType="pubmed">32510328</ArticleId></ArticleIdList></Reference><Reference><Citation>Antar LN, Li C, Zhang H, Carroll RC, Bassell GJ. Local functions for FMRP in axon growth cone motility and activity-dependent regulation of filopodia and spine synapses. Mol Cell Neurosci. 2006;32(1&#x2013;2): 37&#x2013;48. 10.1016/j.mcn.2006.02.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mcn.2006.02.001</ArticleId><ArticleId IdType="pubmed">16631377</ArticleId></ArticleIdList></Reference><Reference><Citation>Li C, Bassell GJ, Sasaki Y. Fragile X mental retardation protein is involved in protein synthesis-dependent collapse of growth cones induced by semaphorin-3A. Front Neural Circuits. 2009;3:11 10.3389/neuro.04.011.2009.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/neuro.04.011.2009</ArticleId><ArticleId IdType="pmc">PMC2759364</ArticleId><ArticleId IdType="pubmed">19826618</ArticleId></ArticleIdList></Reference><Reference><Citation>Dictenberg JB, Swanger SA, Antar LN, Singer RH, Bassell GJ. A direct role for FMRP in activity-dependent dendritic mRNA transport links filopodial-spine morphogenesis to fragile X syndrome. Dev Cell. 2008; 14(6):926&#x2013;939. 10.1016/j.devcel.2008.04.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.devcel.2008.04.003</ArticleId><ArticleId IdType="pmc">PMC2453222</ArticleId><ArticleId IdType="pubmed">18539120</ArticleId></ArticleIdList></Reference><Reference><Citation>Ling S-C, Fahrner PS, Greenough WT, Gelfand VI. Transport of Drosophila fragile X mental retardation protein-containing ribonucleoprotein granules by kinesin-1 and cytoplasmic dynein. Proc Natl Acad Sci USA. 2004;101(50):17428&#x2013;17433. 10.1073/pnas.0408114101.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0408114101</ArticleId><ArticleId IdType="pmc">PMC536039</ArticleId><ArticleId IdType="pubmed">15583137</ArticleId></ArticleIdList></Reference><Reference><Citation>Bianco A, Dienstbier M, Salter HK, Gatto G, Bullock SL. Bicaudal-D regulates fragile X mental retardation protein levels, motility, and function during neuronal morphogenesis. Curr Biol. 2010;20(16): 1487&#x2013;1492. 10.1016/j.cub.2010.07.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cub.2010.07.016</ArticleId><ArticleId IdType="pmc">PMC2927779</ArticleId><ArticleId IdType="pubmed">20691595</ArticleId></ArticleIdList></Reference><Reference><Citation>Lindsay AJ, McCaffrey MW. Myosin Va is required for the transport of fragile X mental retardation protein (FMRP) granules. Biol Cell. 2014;106(2):57&#x2013;71. 10.1111/boc.201200076.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/boc.201200076</ArticleId><ArticleId IdType="pubmed">24175909</ArticleId></ArticleIdList></Reference><Reference><Citation>Estes PS, O'Shea M, Clasen S, Zarnescu DC. Fragile X protein controls the efficacy of mRNA transport in Drosophila neurons. Mol Cell Neurosci. 2008;39(2):170&#x2013;179. 10.1016/j.mcn.2008.06.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mcn.2008.06.012</ArticleId><ArticleId IdType="pubmed">18655836</ArticleId></ArticleIdList></Reference><Reference><Citation>Kao D-I, Aldridge GM, Weiler IJ, Greenough WT. Altered mRNA transport, docking, and protein translation in neurons lacking fragile X mental retardation protein. Proc Natl Acad Sci U S A. 2010;107(35): 15601&#x2013;15606. 10.1073/pnas.1010564107.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1010564107</ArticleId><ArticleId IdType="pmc">PMC2932564</ArticleId><ArticleId IdType="pubmed">20713728</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y, O'Connor JP, Siomi MC, et al. The fragile X mental retardation syndrome protein interacts with novel homologs FXR1 and FXR2. EMBO J. 1995;14(21):5358&#x2013;5366.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC394645</ArticleId><ArticleId IdType="pubmed">7489725</ArticleId></ArticleIdList></Reference><Reference><Citation>Siomi MC, Siomi H, Sauer WH, Srinivasan S, Nussbaum RL, Dreyfuss G. FXR1, an autosomal homolog of the fragile X mental retardation gene. EMBO J. 1995;14(11):2401&#x2013;2408.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC398353</ArticleId><ArticleId IdType="pubmed">7781595</ArticleId></ArticleIdList></Reference><Reference><Citation>Akins MR, Berk-Rauch HE, Kwan KY, et al. Axonal ribosomes and mRNAs associate with fragile X granules in adult rodent and human brains. Hum Mol Genet. 2017;26(1):192&#x2013;209. 10.1093/hmg/ddw381.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddw381</ArticleId><ArticleId IdType="pmc">PMC5815656</ArticleId><ArticleId IdType="pubmed">28082376</ArticleId></ArticleIdList></Reference><Reference><Citation>Christie SB, Akins MR, Schwob JE, Fallon JR. The FXG: a presynaptic fragile X granule expressed in a subset of developing brain circuits. J Neurosci. 2009;29(5):1514&#x2013;1524. 10.1523/JNEUROSCI.3937-08.2009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.3937-08.2009</ArticleId><ArticleId IdType="pmc">PMC2746438</ArticleId><ArticleId IdType="pubmed">19193898</ArticleId></ArticleIdList></Reference><Reference><Citation>Akins MR, Leblanc HF, Stackpole EE, Chyung E, Fallon JR. Systematic mapping of fragile X granules in the mouse brain reveals a potential role for presynaptic FMRP in sensorimotor functions. J Comp Neurol. 2012;520(16):3687&#x2013;3706. 10.1002/cne.23123.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/cne.23123</ArticleId><ArticleId IdType="pmc">PMC3998511</ArticleId><ArticleId IdType="pubmed">22522693</ArticleId></ArticleIdList></Reference><Reference><Citation>Chyung E, LeBlanc HF, Fallon JR, Akins MR. Fragile X granules are a family of axonal ribonucleoprotein particles with circuit-dependent protein composition and mRNA cargos. J Comp Neurol. 2018;526(1): 96&#x2013;108. 10.1002/cne.24321.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/cne.24321</ArticleId><ArticleId IdType="pmc">PMC5810954</ArticleId><ArticleId IdType="pubmed">28884477</ArticleId></ArticleIdList></Reference><Reference><Citation>Nakayama K, Ohashi R, Shinoda Y, et al. RNG105/caprin1, an RNA granule protein for dendritic mRNA localization, is essential for long-term memory formation. eLife. 2017;6:e29677 10.7554/eLife.29677.</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.29677</ArticleId><ArticleId IdType="pmc">PMC5697933</ArticleId><ArticleId IdType="pubmed">29157358</ArticleId></ArticleIdList></Reference><Reference><Citation>Shiina N, Yamaguchi K, Tokunaga M. RNG105 deficiency impairs the dendritic localization of mRNAs for Na+/K+ ATPase subunit isoforms and leads to the degeneration of neuronal networks. J Neurosci. 2010;30(38):12816&#x2013;12830. 10.1523/JNEUROSCI.6386-09.2010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.6386-09.2010</ArticleId><ArticleId IdType="pmc">PMC6633578</ArticleId><ArticleId IdType="pubmed">20861386</ArticleId></ArticleIdList></Reference><Reference><Citation>Jain S, Wheeler JR, Walters RW, Agrawal A, Barsic A, Parker R. ATPase-modulated stress granules contain a diverse proteome and substructure. Cell. 2016;164(3):487&#x2013;498. 10.1016/j.cell.2015.12.038.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2015.12.038</ArticleId><ArticleId IdType="pmc">PMC4733397</ArticleId><ArticleId IdType="pubmed">26777405</ArticleId></ArticleIdList></Reference><Reference><Citation>Markmiller S, Soltanieh S, Server KL, et al. Context-dependent and disease-specific diversity in protein interactions within stress granules. Cell. 2018;172(3):590&#x2013;604.e13. 10.1016/j.cell.2017.12.032.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2017.12.032</ArticleId><ArticleId IdType="pmc">PMC5969999</ArticleId><ArticleId IdType="pubmed">29373831</ArticleId></ArticleIdList></Reference><Reference><Citation>El Fatimy R, Tremblay S, Dury AY, et al. Fragile X mental retardation protein interacts with the RNA-binding protein Caprin1 in neuronal RiboNucleoProtein complexes [corrected]. PLoS One. 2012;7(6): e39338 10.1371/journal.pone.0039338.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0039338</ArticleId><ArticleId IdType="pmc">PMC3380850</ArticleId><ArticleId IdType="pubmed">22737234</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim TH, Tsang B, Vernon RM, Sonenberg N, Kay LE, Forman-Kay JD. Phospho-dependent phase separation of FMRP and CAPRIN1 recapitulates regulation of translation and deadenylation. Science. 2019; 365(6455):825&#x2013;829. 10.1126/science.aax4240.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aax4240</ArticleId><ArticleId IdType="pubmed">31439799</ArticleId></ArticleIdList></Reference><Reference><Citation>Barbee SA, Estes PS, Cziko A-M, et al. Staufen- and FMRP-containing neuronal RNPs are structurally and functionally related to somatic P bodies. Neuron. 2006;52(6):997&#x2013;1009. 10.1016/j.neuron.2006.10.028.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2006.10.028</ArticleId><ArticleId IdType="pmc">PMC1955741</ArticleId><ArticleId IdType="pubmed">17178403</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee EK, Kim HH, Kuwano Y, et al. hnRNP C promotes APP translation by competing with FMRP for APP mRNA recruitment to P bodies. Nat Struct Mol Biol. 2010;17(6):732&#x2013;739. 10.1038/nsmb.1815.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nsmb.1815</ArticleId><ArticleId IdType="pmc">PMC2908492</ArticleId><ArticleId IdType="pubmed">20473314</ArticleId></ArticleIdList></Reference><Reference><Citation>Snead WT, Gladfelter AS. The control centers of biomolecular phase separation: how membrane surfaces, PTMs, and active processes regulate condensation. Mol Cell. 2019;76(2):295&#x2013;305. 10.1016/j.molcel.2019.09.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molcel.2019.09.016</ArticleId><ArticleId IdType="pmc">PMC7173186</ArticleId><ArticleId IdType="pubmed">31604601</ArticleId></ArticleIdList></Reference><Reference><Citation>Cherkasov V, Hofmann S, Druffel-Augustin S, et al. Coordination of translational control and protein homeostasis during severe heat stress. Curr Biol. 2013;23(24):2452&#x2013;2462. 10.1016/j.cub.2013.09.058.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cub.2013.09.058</ArticleId><ArticleId IdType="pubmed">24291094</ArticleId></ArticleIdList></Reference><Reference><Citation>Walters RW, Muhlrad D, Garcia J, Parker R. Differential effects of Ydj1 and Sis1 on Hsp70-mediated clearance of stress granules in Saccharomyces cerevisiae. RNA. 2015;21(9):1660&#x2013;1671. 10.1261/rna.053116.115.</Citation><ArticleIdList><ArticleId IdType="doi">10.1261/rna.053116.115</ArticleId><ArticleId IdType="pmc">PMC4536325</ArticleId><ArticleId IdType="pubmed">26199455</ArticleId></ArticleIdList></Reference><Reference><Citation>Kroschwald S, Maharana S, Mateju D, et al. Promiscuous interactions and protein disaggregases determine the material state of stress-inducible RNP granules. eLife. 2015;4:e06807 10.7554/eLife.06807.</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.06807</ArticleId><ArticleId IdType="pmc">PMC4522596</ArticleId><ArticleId IdType="pubmed">26238190</ArticleId></ArticleIdList></Reference><Reference><Citation>Mateju D, Franzmann TM, Patel A, et al. An aberrant phase transition of stress granules triggered by misfolded protein and prevented by chaperone function. EMBO J. 2017;36(12):1669&#x2013;1687. 10.15252/embj.201695957.</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/embj.201695957</ArticleId><ArticleId IdType="pmc">PMC5470046</ArticleId><ArticleId IdType="pubmed">28377462</ArticleId></ArticleIdList></Reference><Reference><Citation>Marotta NP, Lin YH, Lewis YE, et al. O-GlcNAc modification blocks the aggregation and toxicity of the protein &#x3b1;-synuclein associated with Parkinson's disease. Nat Chem. 2015;7(11):913&#x2013;920. 10.1038/nchem.2361.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nchem.2361</ArticleId><ArticleId IdType="pmc">PMC4618406</ArticleId><ArticleId IdType="pubmed">26492012</ArticleId></ArticleIdList></Reference><Reference><Citation>Yuzwa SA, Shan X, Macauley MS, et al. Increasing O-GlcNAc slows neurodegeneration and stabilizes tau against aggregation. Nat Chem Biol. 2012;8(4):393&#x2013;399. 10.1038/nchembio.797.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nchembio.797</ArticleId><ArticleId IdType="pubmed">22366723</ArticleId></ArticleIdList></Reference><Reference><Citation>Qamar S, Wang G, Randle SJ, et al. FUS phase separation is modulated by a molecular chaperone and methylation of arginine cation-&#x3c0; interactions. Cell. 2018;173(3):720&#x2013;734.e15. 10.1016/j.cell.2018.03.056.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2018.03.056</ArticleId><ArticleId IdType="pmc">PMC5927716</ArticleId><ArticleId IdType="pubmed">29677515</ArticleId></ArticleIdList></Reference><Reference><Citation>Lorton BM, Shechter D. Cellular consequences of arginine methylation. Cell Mol Life Sci. 2019;76(15):2933&#x2013;2956. 10.1007/s00018-019-03140-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00018-019-03140-2</ArticleId><ArticleId IdType="pmc">PMC6642692</ArticleId><ArticleId IdType="pubmed">31101937</ArticleId></ArticleIdList></Reference><Reference><Citation>Carlomagno Y, Chung DC, Yue M, et al. An acetylation-phosphorylation switch that regulates tau aggregation propensity and function. J Biol Chem. 2017;292(37):15277&#x2013;15286. 10.1074/jbc.M117.794602.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M117.794602</ArticleId><ArticleId IdType="pmc">PMC5602388</ArticleId><ArticleId IdType="pubmed">28760828</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang A, Conicella AE, Schmidt HB, et al. A single N-terminal phosphomimic disrupts TDP-43 polymerization, phase separation, and RNA splicing. EMBO J. 2018;37(5):e97452 10.15252/embj.201797452.</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/embj.201797452</ArticleId><ArticleId IdType="pmc">PMC5830921</ArticleId><ArticleId IdType="pubmed">29438978</ArticleId></ArticleIdList></Reference><Reference><Citation>Monahan Z, Ryan VH, Janke AM, et al. Phosphorylation of the FUS low-complexity domain disrupts phase separation, aggregation, and toxicity. EMBO J. 2017;36(20):2951, 10.15252/embj.201696394-2967.</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/embj.201696394-2967</ArticleId><ArticleId IdType="pmc">PMC5641905</ArticleId><ArticleId IdType="pubmed">28790177</ArticleId></ArticleIdList></Reference><Reference><Citation>Ambadipudi S, Biernat J, Riedel D, Mandelkow E, Zweckstetter M. Liquid-liquid phase separation of the microtubule-binding repeats of the Alzheimer-related protein Tau. Nat Commun. 2017;8:275 10.1038/s41467-017-00480-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-017-00480-0</ArticleId><ArticleId IdType="pmc">PMC5561136</ArticleId><ArticleId IdType="pubmed">28819146</ArticleId></ArticleIdList></Reference><Reference><Citation>Herman AB, Silva Afonso M, Kelemen SE, et al. Regulation of stress granule formation by inflammation, vascular injury, and atherosclerosis. Arterioscler Thromb Vasc Biol. 2019;39(10):2014&#x2013;2027. 10.1161/ATVBAHA.119.313034.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/ATVBAHA.119.313034</ArticleId><ArticleId IdType="pmc">PMC6761003</ArticleId><ArticleId IdType="pubmed">31462091</ArticleId></ArticleIdList></Reference><Reference><Citation>Ceman S, O'Donnell WT, Reed M, Patton S, Pohl J, Warren ST. Phosphorylation influences the translation state of FMRP-associated polyribosomes. Hum Mol Genet. 2003;12(24):3295&#x2013;3305. 10.1093/hmg/ddg350.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddg350</ArticleId><ArticleId IdType="pubmed">14570712</ArticleId></ArticleIdList></Reference><Reference><Citation>Narayanan U, Nalavadi V, Nakamoto M, et al. S6K1 phosphorylates and regulates fragile X mental retardation protein (FMRP) with the neuronal protein synthesis-dependent mammalian target of rapamycin (mTOR) signaling cascade. J Biol Chem. 2008;283(27): 18478&#x2013;18482. 10.1074/jbc.C800055200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.C800055200</ArticleId><ArticleId IdType="pmc">PMC2441545</ArticleId><ArticleId IdType="pubmed">18474609</ArticleId></ArticleIdList></Reference><Reference><Citation>Bartley CM, O'Keefe RA, Blice-Baum A, et al. Mammalian FMRP S499 is phosphorylated by CK2 and promotes secondary phosphorylation of FMRP. eNeuro. 2016;3(6):ENEURO.0092&#x2013;ENEU16.2016. 10.1523/ENEURO.0092-16.2016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/ENEURO.0092-16.2016</ArticleId><ArticleId IdType="pmc">PMC5116651</ArticleId><ArticleId IdType="pubmed">27957526</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Y, Tang W, Zhang L, Zhang C. FMRP regulates miR196a-mediated repression of HOXB8 via interaction with the AGO2 MID domain. Mol Biosyst. 2014;10(7):1757&#x2013;1764. 10.1039/c4mb00066h.</Citation><ArticleIdList><ArticleId IdType="doi">10.1039/c4mb00066h</ArticleId><ArticleId IdType="pubmed">24727796</ArticleId></ArticleIdList></Reference><Reference><Citation>Narayanan U, Nalavadi V, Nakamoto M, et al. FMRP phosphorylation reveals an immediate-early signaling pathway triggered by group I mGluR and mediated by PP2A. J Neurosci. 2007;27(52):14349&#x2013;14357. 10.1523/JNEUROSCI.2969-07.2007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.2969-07.2007</ArticleId><ArticleId IdType="pmc">PMC6673448</ArticleId><ArticleId IdType="pubmed">18160642</ArticleId></ArticleIdList></Reference><Reference><Citation>Hou L, Antion MD, Hu D, Spencer CM, Paylor R, Klann E. Dynamic translational and proteasomal regulation of fragile X mental retardation protein controls mGluR-dependent long-term depression. Neuron. 2006;51(4):441&#x2013;454. 10.1016/j.neuron.2006.07.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2006.07.005</ArticleId><ArticleId IdType="pubmed">16908410</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang J, Ikeuchi Y, Malumbres M, Bonni A. A Cdh1-APC/FMRP ubiquitin signaling link drives mGluR-dependent synaptic plasticity in the mammalian brain. Neuron. 2015;86(3):726&#x2013;739. 10.1016/j.neuron.2015.03.049.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2015.03.049</ArticleId><ArticleId IdType="pmc">PMC4492466</ArticleId><ArticleId IdType="pubmed">25913861</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsang B, Arsenault J, Vernon RM, et al. Phosphoregulated FMRP phase separation models activity-dependent translation through bidirectional control of mRNA granule formation. Proc Natl Acad Sci U S A. 2019;116 (10):4218&#x2013;4227. 10.1073/pnas.1814385116.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1814385116</ArticleId><ArticleId IdType="pmc">PMC6410804</ArticleId><ArticleId IdType="pubmed">30765518</ArticleId></ArticleIdList></Reference><Reference><Citation>Mazroui R, Di Marco S, Kaufman RJ, Gallouzi I-E. Inhibition of the ubiquitin-proteasome system induces stress granule formation. Mol Biol Cell. 2007;18(7):2603&#x2013;2618. 10.1091/mbc.e06-12-1079.</Citation><ArticleIdList><ArticleId IdType="doi">10.1091/mbc.e06-12-1079</ArticleId><ArticleId IdType="pmc">PMC1924830</ArticleId><ArticleId IdType="pubmed">17475769</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie X, Matsumoto S, Endo A, et al. Deubiquitylases USP5 and USP13 are recruited to and regulate heat-induced stress granules through their deubiquitylating activities. J Cell Sci. 2018;131(8):jcs210856 10.1242/jcs.210856.</Citation><ArticleIdList><ArticleId IdType="doi">10.1242/jcs.210856</ArticleId><ArticleId IdType="pubmed">29567855</ArticleId></ArticleIdList></Reference><Reference><Citation>Valdez-Sinon AN, Lai A, Shi L, et al. Cdh1-APC regulates protein synthesis and stress granules in neurons through an FMRP-dependent mechanism. iScience. 2020;101132.23(5). 10.1016/j.isci.2020.101132.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.isci.2020.101132</ArticleId><ArticleId IdType="pmc">PMC7236060</ArticleId><ArticleId IdType="pubmed">32434143</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>